Skip to content
Contact
0

Bowel Diseases

Home » Disease Area » Bowel Diseases » Page 2

Showing 19–36 of 37 results

Lactose Intolerance quick test

Endoscopy
The BIOHIT Lactose Intolerance Quick Test is a rapid enzymatic test for the determination of lactase in duodenal biopsies. Uned in endoscopy in conjunction with OGD (upper endoscopy) the Lactose Intolerance quick test supports the diagnosis of hypolactasia of the small intestine from a single biopsy specimen.

Zonulin (Stool) ELISA (IDK®)

Lab assay
The IDK Zonulin (Stool) ELISA is a quantitative assay designed for the precise determination of zonulin levels in stool samples. Zonulin, a protein intricately involved in intestinal barrier function, has garnered attention as a potential marker for the phenomenon commonly known as "leaky gut" syndrome.

IDK® Zonulin (Stool) ELISA

Lab assay
The IDK Zonulin (Serum) ELISA is a quantitative assay for the determination of zonulin in serum. Zonulin is a protein that is involved in intestinal barrier function, regulating tight junctions and increasing intestinal epithelium permeability. It has been highlighted as a potential marker of “leaky gut” syndrome.

IDK® Faecal Lactoferrin ELISA

Lab assay
The IDK Fecal Lactoferrin ELISA is an enzyme immunoassay for the quantitative determination of lactoferrin – a well-established biomarker for neutrophilic intestinal inflammation – in stool samples. Faecal lactoferrin measurement supports monitoring of disease activity in inflammatory bowel disease (IBD), prediction of relapse of IBD and assessment of treatment response in IBD.

IDK® Faecal Calprotectin ELISA

Lab assay
The IDK Faecal Calprotectin ELISA is an enzyme immunoassay for the quantitative determination of human calprotectin (MRP 8/14; S100A8/A9) in stool samples, to rule out and monitor inflammatory bowel diseases (IBDs) non-invasively.

IDK® Faecal Bile Acids assay

Lab assay
The IDK Fecal Bile Acids assay allows quantitative determination of bile acids in stool samples. This rapid photometric assay can aid the diagnosis of bile acid diarrhoea in patients with diarrhoea-predominant irritable bowel syndrome (D-IBS) or chronic diarrhoea in patients who have undergone chloecystectomy or intestinal resection.

IDK® Faecal Haemoglobin ELISA

Lab assay
The IDK Fecal Haemoglobin (FIT) ELISA stands as a cutting-edge enzyme immunoassay designed to deliver precise quantitative measurements of human haemoglobin in stool samples. This assay serves as a crucial marker for identifying early colorectal cancer and adenomatous polyps by detecting gastrointestinal bleeding, particularly originating from colorectal adenomas and tumours.

Vedolizumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
The IDKmonitor Vedolizumab Free Anti-drug ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free anti-vedolizumab antibodies in plasma or serum samples. Detecting high levels of free anti-vedolizumab antibodies in patients when the drug level is low (undetectable or sub-therapeutic) may indicate poorer long-term outcomes and suggest the need to switch treatment.

Vedolizumab Drug Level ELISA (IDKmonitor®)

Lab assay
Vedolizumab is a recombinant protein used to treat Crohn's disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.

Ustekinumab Drug Level ELISA (IDKmonitor®)

Lab assay
Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.

Infliximab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Infliximab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (both free- nd bound antibodies) in serum and plasma.

Infliximab Drug Level ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

Golimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples.

Adalimumab Total Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Adalimumab Total Anti-drug ELISA kit is a ‘drug tolerant’ assay that enables the detection of anti-drug antibodies in the presence of circulating drug (free- and bound- anti-drug antibodies) in serum and plasma.

Adalimumab Drug Level ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat inflammatory bowel disease (IBD) and other chronic inflammatory conditions. The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free adalimumab from plasma or serum samples.

Infliximab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation which is a major cause of loss of drug response.

Golimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response.

Adalimumab Free Anti-drug Antibody ELISA (IDKmonitor®)

Lab assay
Adalimumab is a recombinant anti-TNFα therapeutic monoclonal antibody used to treat chronic inflammatory diseases. This protein can induce humoral immune responses and lead to anti-drug antibody formation, which is a major cause of loss of drug response. The IDKmonitor Free Anti-drug antibody ELISA detects free (non-drug bound) antibodies to Adalimumab in serum and plasma.

Showing 19–36 of 37 results

Show all products